Mounjaro mounts to top spot in Indian drug market; Oct sales touch ₹100 cr, ETPharma
New Delhi: Maintaining its growth momentum for the seventh straight month, Eli Lilly’s type-2 diabetes and weight-loss drug…
GLP-1 goliath updates demand for top weight loss drug
Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss drug Wegovy,…
Is Eli Lilly a Millionaire Maker?
Eli Lilly’s GLP-1 drug portfolio should power the business for at least the next decade. But the market…
After Her Unfiltered Body Selfie Went Viral, Amy Schumer Said She’s “Enjoying” How She Looks And Shared More Photos Of Herself Post-Mounjaro
Earlier this year, Amy Schumer opened up about using the drug Mounjaro for weight loss. Gilbert Carrasquillo /…
Ozempic at Costco? Discount Giant Expands Into $100 Billion Weight-Loss Drug Market
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Costco…
Ozempic coming soon to India: What is it? Benefits, side effects and controversies
India’s drug controller, the Central Drugs Standard Control Organisation (CDSCO), approved Ozempic (semaglutide) on 26 September for use…
1 Reason Novo Nordisk (NVO) Is 1 of the Best Healthcare Stocks You Can Buy Today
Novo Nordisk is leading the race to get an oral weight loss GLP-1 drug approved. It needs to…
How the ‘Ozempic effect’ is reshaping the global economy
Michael Siluk/Alamy The new wave of weight-loss drugs has taken the world by storm. From Novo Nordisk’s Ozempic…
Hepatologist ‘The Liver Doc’ reveals why people must take weight loss drug Mounjaro and who should avoid it
‘Weight loss drugs have been criticised more than they have been accepted over the past few years, after…